Monash IVF Group Management

Management criteria checks 3/4

Monash IVF Group's CEO is Michael Knaap, appointed in Oct 2018, has a tenure of 5.5 years. total yearly compensation is A$1.04M, comprised of 54.6% salary and 45.4% bonuses, including company stock and options. directly owns 0.039% of the company’s shares, worth A$217.72K. The average tenure of the management team and the board of directors is 4.8 years and 8.7 years respectively.

Key information

Michael Knaap

Chief executive officer

AU$1.0m

Total compensation

CEO salary percentage	54.6%
CEO tenure	5.5yrs
CEO ownership	0.04%
Management average tenure	4.8yrs
Board average tenure	8.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Knaap's remuneration changed compared to Monash IVF Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	AU$24m
Sep 30 2023	n/a	n/a	AU$23m
Jun 30 2023	AU$1m	AU$567k	AU$22m
Mar 31 2023	n/a	n/a	AU$19m
Dec 31 2022	n/a	n/a	AU$17m
Sep 30 2022	n/a	n/a	AU$18m
Jun 30 2022	AU$794k	AU$552k	AU$18m
Mar 31 2022	n/a	n/a	AU$21m
Dec 31 2021	n/a	n/a	AU$23m
Sep 30 2021	n/a	n/a	AU$24m
Jun 30 2021	AU$908k	AU$501k	AU$25m
Mar 31 2021	n/a	n/a	AU$22m
Dec 31 2020	n/a	n/a	AU$18m
Sep 30 2020	n/a	n/a	AU$15m
Jun 30 2020	AU$561k	AU$479k	AU$12m
Mar 31 2020	n/a	n/a	AU$15m
Dec 31 2019	n/a	n/a	AU$18m
Sep 30 2019	n/a	n/a	AU$19m
Jun 30 2019	AU$520k	AU$402k	AU$20m
Mar 31 2019	n/a	n/a	AU$19m
Dec 31 2018	n/a	n/a	AU$19m
Sep 30 2018	n/a	n/a	AU$20m
Jun 30 2018	AU$424k	AU$350k	AU$21m
Mar 31 2018	n/a	n/a	AU$24m
Dec 31 2017	n/a	n/a	AU$26m
Sep 30 2017	n/a	n/a	AU$28m
Jun 30 2017	AU$466k	AU$340k	AU$30m

Compensation vs Market: Michael's total compensation ($USD682.98K) is about average for companies of similar size in the Australian market ($USD779.72K).

Compensation vs Earnings: Michael's compensation has increased by more than 20% in the past year.

CEO

Michael Knaap

5.5yrs

Tenure

AU$1,038,539

Compensation

Mr. Michael D. Knaap serves as Chief Executive Officer, Managing Director and Executive Director of Monash IVF Group Limited since April 15, 2019. Mr. Knaap served as an Interim Chief Executive Officer of...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Michael Knaap	CEO, MD & Executive Director	5.5yrs	AU$1.04m	0.039% A$ 217.7k
Malik Jainudeen	Group CFO & Company Secretary	5yrs	AU$511.77k	0.0049% A$ 27.8k
Hamish Hamilton	Chief Operating Officer	4.1yrs	AU$504.44k	0.032% A$ 178.9k
Richard Henshaw	Executive Director	10yrs	AU$343.97k	0.35% A$ 2.0m
Deirdre Zander-Fox	Chief Scientific Officer	no data	no data	no data
Thierry Panthier	Chief Information Officer	2.3yrs	no data	no data
Fiona Allen	Chief Marketing Officer	4.8yrs	no data	no data
Peggy North	Chief People & Culture Officer	no data	no data	no data
Tedd Fuell	Chief Governance & Risk Officer	no data	no data	no data
Johannes Lagerwij	Managing Director of Asia	1.3yrs	no data	no data

4.8yrs

Average Tenure

Experienced Management: MVF's management team is considered experienced (4.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Michael Knaap	CEO, MD & Executive Director	5yrs	AU$1.04m	0.039% A$ 217.7k
Richard Henshaw	Executive Director	10yrs	AU$343.97k	0.35% A$ 2.0m
Neil Broekhuizen	Independent Non-Executive Director	9.8yrs	AU$102.53k	0.090% A$ 505.8k
Josef Czyzewski	Independent Non-Executive Director	9.8yrs	AU$120.36k	0.062% A$ 348.8k
Richard Davis	Independent Non-Executive Chairman	9.8yrs	AU$168.27k	0.047% A$ 263.1k
Zita Peach	Independent Non-Executive Director	7.5yrs	AU$111.46k	0.024% A$ 134.1k
Catherine West	Independent Non-Executive Director	3.6yrs	AU$102.53k	0.0095% A$ 53.6k
Catherine Aston	Independent Non-Executive Director	less than a year	no data	no data

8.7yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MVF's board of directors are considered experienced (8.7 years average tenure).

Monash IVF Group Management

Management criteria checks 3/4

Key information

Recent management updates

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Insufficient new directors

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Insufficient new directors

Independent Non-Executive Director recently bought AU$192k worth of stock

Recent updates

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age